Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 4
1983 7
1984 4
1986 2
1987 4
1988 3
1989 2
1990 1
1997 2
1998 1
1999 1
2001 2
2006 1
2008 2
2009 3
2010 7
2011 7
2012 4
2013 5
2014 8
2015 4
2016 5
2017 6
2018 8
2019 13
2020 7
2021 5
2022 6
2023 4
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Yonese J, Hinata N, Masui S, Nakai Y, Shirotake S, Takeuchi A, Inamoto T, Nozawa M, Ueda K, Etsunaga T, Osawa T, Uemura M, Kimura G, Numakura K, Yamana K, Miyake H, Fukasawa S, Morishima N, Ito H, Uemura H. Yonese J, et al. Among authors: shirotake s. Int J Urol. 2023 Sep;30(9):762-771. doi: 10.1111/iju.15206. Epub 2023 May 29. Int J Urol. 2023. PMID: 37248753
Test-retest repeatability of quantitative bone SPECT/CT.
Yamane T, Fukushima K, Shirotake S, Nishimoto K, Okabe T, Oyama M, Seto A, Kuji I. Yamane T, et al. Among authors: shirotake s. Ann Nucl Med. 2021 Mar;35(3):338-346. doi: 10.1007/s12149-020-01568-2. Epub 2021 Jan 5. Ann Nucl Med. 2021. PMID: 33400148
Association between immune-related adverse events and survival in patients with renal cell carcinoma treated with nivolumab plus ipilimumab: immortal time bias-corrected analysis.
Washino S, Shirotake S, Takeshita H, Inoue M, Miura Y, Hyodo Y, Kagawa M, Izumi K, Oyama M, Kawakami S, Saito K, Matsuoka Y, Taniuchi S, Shintani A, Miyagawa T. Washino S, et al. Among authors: shirotake s. Int J Clin Oncol. 2023 Dec;28(12):1651-1658. doi: 10.1007/s10147-023-02406-x. Epub 2023 Sep 2. Int J Clin Oncol. 2023. PMID: 37658926
Robot-Assisted Partial Cystectomy Using the "Double Bipolar Method".
Hamasaki S, Kaneko G, Yabuno A, Miyama Y, Hiruta S, Hagiwara M, Shirotake S, Yasuda M, Oyama M. Hamasaki S, et al. Among authors: shirotake s. Cureus. 2024 Jun 3;16(6):e61610. doi: 10.7759/cureus.61610. eCollection 2024 Jun. Cureus. 2024. PMID: 38962625 Free PMC article.
116 results